Assessment of Predictive Role of Urodynamics in Sacral Neuromodulation Patients
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Overactive Bladder
- Sponsor
- Universiteit Antwerpen
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Change in bladder sensation
- Last Updated
- 6 years ago
Overview
Brief Summary
In the field of urology, sacral neuromodulation (SNM) is a well-accepted, second-line, minimally invasive treatment for patients with overactive bladder dry (OABD) or wet (OABW), and for patients with non-obstructive urinary retention (NOUR).
Long-term vary between 50-60%. This study examines whether urodynamics can be used as a predictor for successful SNM therapy
Investigators
Donald Vaganée
Principal Investigator
Universiteit Antwerpen
Eligibility Criteria
Inclusion Criteria
- •Overactive bladder
- •Non-obstructive urinary retention
Exclusion Criteria
- •Neurogenica disorder (e.g. cerebrovascular accident, spinal cord injury)
Outcomes
Primary Outcomes
Change in bladder sensation
Time Frame: 3 weeks
Bladder sensation is measured by a slider (indicating bladder fullness scaled from 0 to 100) before and after test procedure for sacral neuromodulation
Change in bladder volume
Time Frame: 3 weeks
Change in bladder volume is measured before and after test procedure for sacral neuromodulation
Change in ice water test
Time Frame: 3 weeks
Ice water is infused in the bladder and incontinence upon insertion of the ice water is assessed before and after sacral neuromodulation